So far the analysts covering this stock have laid kind of low....you would think that if this was cut and dry, they would have immediately downgraded the stock....they are probably also waiting to find out exactly what happened, who was to blame, and if there is some kind of legal recourse as an option?
It seems some of the sellers went with the.....sell now and ask questions later, or just sell now and get the hell out of Dodge. They may have made a big mistake as the stock price so far has held up very well...much better than I thought it was going to after the initial news came out.
Once again, while the third quarter revenues were not great, they did add to their backlog and like has been mentioned before, when these late stage drugs get approved, this backlog turns into revenue and profit.....well at $200 million in annual revenue this should be a pretty decent cash cow and it only gets better as the revenue climbs......assuming the sales are there!!
So yes I do hope that we get a CC and find out exactly what happened and what happens now.
At the very least, the new convertible gives them lots of time to right the ship and fill up the capacity!
Still think a buyout may be in the offing here, but if so, hopefully the stock price recovers enough by then to at least warrant a $15 plus buyout?
Very curious to find out more!!!
News 
Market Data 
Discover 
AI
